Chapter 2 Diverse Mechanisms of Endogenous Nucleobase Deamination in DNA and RNA

Advances in Molecular Toxicology

Volumn 1, Issue C, 2006, Pages 25-63

  Dedon, Peter C ^a   Barth, Marita ^a   Chen, Bingzi ^a   De Mott, Michael ^a   Dendroulakis, Vasileios ^a   Dong, Min ^a   Kalinga, Shiva ^a   Elmquist, Eric ^a   Margolin, Yelena ^a   Pang, Bo ^a   Zhou, Xinfeng ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 76649093006     PISSN: 18720854     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1872-0854(06)01002-2     Document Type: Review

References (215)

1. De Bont R., and van Larebeke N. Endogenous DNA damage in humans: a review of quantitative data. Mutagenesis 19 (2004) 169-185
2. Lindahl T. Instability and decay of the primary structure of DNA. Nature 362 (1993) 709-714
3. Suzuki T., Matsumura Y., Ide H., Kanaori K., Tajima K., and Makino K. Deglycosylation susceptibility and base-pairing stability of 2′-deoxyoxanosine in oligodeoxynucleotide. Biochemistry 36 (1997) 8013-8019
4. Wuenschell G.E., O'Connor T.R., and Termini J. Stability, miscoding potential, and repair of 2′-deoxyxanthosine in DNA: implications for nitric oxide-induced mutagenesis. Biochemistry 42 (2003) 3608-3616
5. Vongchampa V., Dong M., Gingipalli L., and Dedon P. Stability of 2′-deoxyxanthosine in DNA. Nucleic Acids Res. 31 (2003) 1045-1051
6. Lindahl T., and Nyberg B. Rate of depurination of native deoxyribonucleic acid. Biochemistry 11 (1972) 3610-3618
7. Bender M.L. Mechanisms of Homogeneous Catalysis from Protons to Proteins (1971), Wiley-Interscience, New York
8. Zoltewicz J.A., Clark D.F., Sharpless T.W., and Grahe G. Kinetics and mechanism of the acid-catalyzed hydrolysis of some purine nucleosides. J. Am. Chem. Soc. 92 (1970) 1741-1749
9. Venner H. Research on nucleic acids. XII. Stability of the N-glycoside bond of nucleotides. Hoppe Seylers Z. Physiol. Chem. 344 (1966) 189-196
10. Roy K.B., and Miles H.T. Tautomerism and ionization of xanthosine. Nucleos. Nucleot. 2 (1983) 231-242
11. Herrero-Jimenez P., Tomita-Mitchell A., Furth E.E., Morgenthaler S., and Thilly W.G. Population risk and physiological rate parameters for colon cancer. The union of an explicit model for carcinogenesis with the public health records of the United States. Mutat. Res. 447 (2000) 73-116
12. Kirsh M.E., Cutler R.G., and Hartman P.E. Absence of deoxyuridine and 5-hydroxymethyldeoxyuridine in the DNA from three tissues of mice of various ages. Mech. Ageing Dev. 35 (1986) 71-77
13. Green D.A., and Deutsch W.A. Direct determination of uracil in [32P,uracil-3H]poly(dA.dT) and bisulfite-treated phage PM2 DNA. Anal. Biochem. 142 (1984) 497-503
14. Wickramasinghe S.N., and Fida S. Misincorporation of uracil into the DNA of folate- and B12-deficient HL60 cells. Eur. J. Haematol. 50 (1993) 127-132
15. Goulian M., Bleile B., and Tseng B.Y. Methotrexate-induced misincorporation of uracil into DNA. Proc. Natl. Acad. Sci. USA 77 (1980) 1956-1960
16. Dong M., Wang C., Deen W.M., and Dedon P.C. Absence of 2′-deoxyoxanosine and presence of abasic sites in DNA exposed to nitric oxide at controlled physiological concentrations. Chem. Res. Toxicol. 16 (2003) 1044-1055
17. Mashiyama S.T., Courtemanche C., Elson-Schwab I., Crott J., Lee B.L., Ong C.N., Fenech M., and Ames B.N. Uracil in DNA, determined by an improved assay, is increased when deoxynucleosides are added to folate-deficient cultured human lymphocytes. Anal. Biochem. 330 (2004) 58-69
18. Caulfield J.L., Wishnok J.S., and Tannenbaum S.R. Nitric oxide-induced deamination of cytosine and guanine in deoxynucleosides and oligonucleotides. J. Biol. Chem. 273 (1998) 12689-12695
19. Spencer J.P., Whiteman M., Jenner A., and Halliwell B. Nitrite-induced deamination and hypochlorite-induced oxidation of DNA in intact human respiratory tract epithelial cells. Free Radical Biol. Med. 28 (2000) 1039-1050
20. Nguyen T., Brunson D., Crespi C.L., Penman B.W., Wishnok J.S., and Tannenbaum S.R. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc. Natl. Acad. Sci. USA 89 (1992) 3030-3034
21. Lucas L.T., Gatehouse D., Jones G.D.D., and Shuker D.E.G. Characterization of DNA damage at purine residues in oligonucleotides and calf thymus DNA induced by the mutagen 1-nitrosoindole-3-acetonitrile. Chem. Res. Toxicol. 14 (2001) 158-164
22. Lucas L.T., Gatehouse D., and Shuker D.E. Efficient nitroso group transfer from N-nitrosoindoles to nucleotides and 2′-deoxyguanosine at physiological pH. A new pathway for N-nitrosocompounds to exert genotoxicity. J. Biol. Chem. 274 (1999) 18319-18326
23. Suzuki T., Yamaoka R., Nishi M., Ide H., and Makino K. Isolation and characterization of a novel product, 2′-deoxyoxanosine, from 2′-deoxyguanosine, oligodeoxynucleotide, and calf thymus DNA treated with nitrous acid and nitric oxide. J. Am. Chem. Soc. 118 (1996) 2515-2516
24. Polson A.G., Crain P.F., Pomerantz S.C., McCloskey J.A., and Bass B.L. The mechanism of adenosine to inosine conversion by the double-stranded RNA unwinding/modifying activity: a high-performance liquid chromatography-mass spectrometry analysis. Biochemistry 30 (1991) 11507-11514
25. Reynaud C.A., Aoufouchi S., Faili A., and Weill J.C. What role for AID: mutator or assembler of the immunoglobulin mutasome?. Nat. Immunol. 4 (2003) 631-638
26. Krokan H.E., Drablos F., and Slupphaug G. Uracil in DNA - occurrence consequences and repair. Oncogene 21 (2002) 8935-8948
27. Bass B.L. RNA editing by adenosine deaminases that act on RNA. Annu. Rev. Biochem. 71 (2002) 817-846
28. Bass B.L. RNA editing and hypermutation by adenosine deamination. Trends Biochem. Sci. 22 (1997) 157-162
29. Anant S., and Davidson N.O. Hydrolytic nucleoside and nucleotide deamination and genetic instability: a possible link between RNA-editing enzymes and cancer?. Trends Mol. Med. 9 (2003) 147-152
30. Maynes J.T., Yuan R.G., and Snyder F.F. Identification expression, and characterization of Escherichia coli guanine deaminase. J. Bacteriol. 182 (2000) 4658-4660
31. Snyder F.F., Yuan R.G., Bin J.C., Carter K.L., and McKay D.J. Human guanine deaminase: cloning expression and characterisation. Adv. Exp. Med. Biol. 486 (2000) 111-114
32. Dong M., and Dedon P.C. Relatively small increases in the steady-state levels of nucleobase deamination products in DNA from human TK6 cells exposed to toxic levels of nitric oxide. Chem. Res. Toxicol. 19 (2006) 50-57
33. Cohen R.M., and Wolfenden R. Cytidine deaminase from Escherichia coli. Purification, properties and inhibition by the potential transition state analog 3,4,5,6-tetrahydrouridine. J. Biol. Chem. 246 (1971) 7561-7565
34. Hong M.Y., and Hosmane R.S. Irreversible tight-binding inhibition of adenosine deaminase by coformycins: inhibitor structural features that contribute to the mode of enzyme inhibition. Nucleos. Nucleot. 16 (1997) 1053-1057
35. Rajappan V.P., and Hosmane R.S. Investigations into biochemical mode of inhibition of guanase by azepinomycin: synthesis and biochemical screening of several analogues of azepinomycin. Nucleos. Nucleot. 18 (1999) 835-836
36. Wang L., and Hosmane R.S. A unique ring-expanded acyclic nucleoside analogue that inhibits both adenosine deaminase (ADA) and guanine deaminase (GDA; guanase): synthesis and enzyme inhibition studies of 4,6-diamino-8H-1-hydroxyethoxymethyl-8-iminoimidazo[4,5-e][1,3]diazepine . Bioorg. Med. Chem. Lett. 11 (2001) 2893-2896
37. Shapiro R., DiFate V., and Welcher M. Deamination of cytosine derivatives by bisulfite. Mechanism of the reaction. J. Am. Chem. Soc. 96 (1974) 206-212
38. Barnes D.E., and Lindahl T. Repair and genetic consequences of endogenous DNA base damage in mammalian cells. Annu. Rev. Genet. 38 (2004) 445-476
39. Holliday R., and Grigg G.W. DNA methylation and mutation. Mutat. Res. 285 (1993) 61-67
40. Lutsenko E., and Bhagwat A.S. Principal causes of hot spots for cytosine to thymine mutations at sites of cytosine methylation in growing cells. A model, its experimental support and implications. Mutat. Res. 437 (1999) 11-20
41. Lindahl T., and Nyberg B. Heat-induced deamination of cytosine residues in deoxyribonucleic acid. Biochemistry 13 (1974) 3405-3410
42. Shapiro R., and Klein R.S. The deamination of cytidine and cytosine by acidic buffer solutions. Mutagenic implications. Biochemistry 5 (1966) 2358-2362
43. Frederico L.A., Kunkel T.A., and Shaw B.R. A sensitive genetic assay for the detection of cytosine deamination: determination of rate constants and the activation energy. Biochemistry 29 (1990) 2532-2537
44. Zhang X., and Mathews C.K. Effect of DNA cytosine methylation upon deamination-induced mutagenesis in a natural target sequence in duplex DNA. J. Biol. Chem. 269 (1994) 7066-7069
45. Shen J.-C., Rideout III W.M., and Jones P.A. The rate of hydrolytic deamination of 5-methylcytosine in double-stranded DNA. Nucleic Acids Res. 22 (1994) 972-976
46. Pfeifer G.P., and Denissenko M.F. Formation and repair of DNA lesions in the p53 gene: relation to cancer mutations?. Environ. Mol. Mutagen 31 (1998) 197-205
47. Pfeifer G.P., Denissenko M.F., Olivier M., Tretyakova N., Hecht S.S., and Hainaut P. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene 21 (2002) 7435-7451
48. Bartsch H., and Spiegelhalder B. Environmental exposure to N-nitroso compounds (NNOC) and precursors: an overview. Eur. J. Cancer Prev. 5 Suppl. 1 (1996) 11-17
49. Ohshima H., Tatemichi M., and Sawa T. Chemical basis of inflammation-induced carcinogenesis. Arch. Biochem. Biophys. 417 (2003) 3-11
50. Ohshima H. Genetic and epigenetic damage induced by reactive nitrogen species: implications in carcinogenesis. Toxicol. Lett. 140-141 (2003) 99-104
51. Balkwill F., and Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 357 (2001) 539-545
52. E. Shacter, S.A. Weitzman, Chronic inflammation and cancer, Oncology (Huntingt.) 16 (2002) 217-226, 229; discussion 230-232.
53. Levin B. Ulcerative colitis and colon cancer: biology and surveillance. J. Cell Biochem. Suppl. 16G (1992) 47-50
54. Farrell R.J., and Peppercorn M.A. Ulcerative colitis. Lancet 359 (2002) 331-340
55. Asaka M., Takeda H., Sugiyama T., and Kato M. What role does Helicobacter pylori play in gastric cancer?. Gastroenterology 113 (1997) S56-S60
56. Ebert M.P., Yu J., Sung J.J., and Malfertheiner P. Molecular alterations in gastric cancer: the role of Helicobacter pylori. Eur. J. Gastroenterol. Hepatol. 12 (2000) 795-798
57. Badawi A.F., Mostafa M.H., Probert A., and O'Connor P.J. Role of schistosomiasis in human bladder cancer: evidence of association, aetiological factors, and basic mechanisms of carcinogenesis. Eur. J. Cancer Prev. 4 (1995) 45-59
58. Mostafa M.H., Sheweita S.A., and O'Connor P.J. Relationship between schistosomiasis and bladder cancer. Clin. Microbiol. Rev. 12 (1999) 97-111
59. D.I. Feig, T.M. Reid, L.A. Loeb, Reactive oxygen species in tumorigenesis, Cancer Res. 54 (1994) 1890s-1894s.
60. Grisham M.B., Jourd'heuil D., and Wink D.A. Review article: chronic inflammation and reactive oxygen and nitrogen metabolism - implications in DNA damage and mutagenesis. Aliment Pharmacol. Ther. 14 Suppl. 1 (2000) 3-9
61. Ambs S., Hussain S.P., Marrogi A.J., and Harris C.C. Cancer-prone oxyradical overload disease. IARC Sci. Publ. 150 (1999) 295-302
62. Jaiswal M., LaRusso N.F., and Gores G.J. Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis. Am. J. Physiol. Gastrointest. Liver Physiol. 281 (2001) G626-G634
63. Dedon P.C., and Tannenbaum S.R. Reactive nitrogen species in the chemical biology of inflammation. Arch. Biochem. Biophys. 423 (2004) 12-22
64. Bredt D.S., and Snyder S.H. Nitric Oxide: Physiol. Messenger Mol. 63 (1994) 175-195
65. Gross S.S., and Wolin M.S. Nitric oxide: pathophysiological mechanisms. Annu. Rev. Physiol. 57 (1995) 737-769
66. Lancaster Jr. J.R. Nitric oxide in cells. Am. Sci. 80 (1992) 248-259
67. MacMicking J., Xie Q., and Nathan C. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15 (1997) 323-350
68. Moncada S., Palmer R.M.J., and Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43 (1991) 109-142
69. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6 (1992) 3051-3064
70. Tamir S., and Tannenbaum S.R. The role of nitric oxide (NO) in the carcinogenic process. Biochem. Biophys. Acta 1288 (1996) F31-F36
71. Lewis R.S., Tamir S., Tannenbaum S.R., and Deen W.M. Kinetic analysis of the fate of nitric oxide synthesized by macrophages in vitro. J. Biol. Chem. 270 (1995) 29350-29355
72. Miwa M., Stuehr D.J., Marletta M.A., Wishnok J.S., and Tannenbaum S.R. Nitrosation of amines by stimulated macrophages. Carcinogenesis 8 (1987) 955-958
73. Stuehr D.J., and Marletta M.A. Synthesis of nitrite and nitrate in murine macrophage cell lines. Cancer Res. 47 (1987) 5590-5594
74. Ohshima H., and Bartsch H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat. Res. 305 (1994) 253-264
75. Pavlick K.P., Laroux F.S., Fuseler J., Wolf R.E., Gray L., Hoffman J., and Grisham M.B. Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease. Free Radic. Biol. Med. 33 (2002) 311-322
76. Singer I.I., Kawka D.W., Scott S., Weidner J.R., Mumford R.A., Riehl T.E., and Stenson W.F. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology 111 (1996) 871-885
77. Hibbs J.B., Taintor R.R., Vavrin Z., and Rachlin E.M. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biophys. Res. Comm. 157 (1988) 87-94
78. Hibbs J.B., Vavrin Z., and Taintor R.R. l-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J. Immunol. 138 (1987) 550-565
79. Chen B., Keshive M., and Deen W.M. Diffusion and reaction of nitric oxide in suspension cell cultures. Biophys. J. 75 (1998) 745-754
80. Chen B., and Deen W.M. Analysis of the effects of cell spacing and liquid depth on nitric oxide and its oxidation products in cell cultures. Chem. Res. Toxicol. 14 (2001) 135-147
81. Suzuki T., Kanaori K., Tajima K., and Makino K. Mechanism and intermediate for formation of 2′-deoxyoxanosine. Nucleic Acids Symp. Ser. 37 (1997) 313-314
82. Dubelman S., and Shapiro R. A method for the isolation of cross-linked nucleosides from DNA: application to cross-links induced by nitrous acid. Nucleic Acids Res. 4 (1977) 1815-1827
83. Shapiro R., and Pohl S.H. The reaction of ribonucleosides with nitrous acid. Side products and kinetics. Biochemistry 7 (1968) 448-455
84. Shapiro R., and Yamaguchi H. Nucleic acid reactivity and conformation. I. Deamination of cytosine by nitrous acid. Biochim. Biophys. Acta 281 (1972) 501-506
85. Tannenbaum S.R., Tamir S., deRojas-Walker T., and Wishnok J.S. DNA damage and cytoxicity by nitric oxide. In: Loeppky R.N., and Michejda C.J. (Eds). Nitrosamines and Related N-nitroso Compounds: Chemistry and Biochemistry (1994), American Chemical Society, Washington, DC 120-135
86. Caulfield J.L., Wishnok J.S., and Tannenbaum S.R. Nitric oxide-induced interstrand cross-links in DNA. Chem. Res. Toxicol. 16 (2003) 571-574
87. Wink D.A., Kasprzak K.S., Maragos C.M., Elespuru R.K., Misra M., Dunams T.M., Cebula T.A., Koch W.H., Andrews A.W., Allen J.S., and Keefer L.K. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 254 (1991) 1001-1003
88. Kirchner J.J., Sigurdsson S.T., and Hopkins P.B. Interstrand cross-linking of duplex DNA by nitrous acid: covalent structure of the dG-to-dG cross-link at the sequence 5′-CG. J. Am. Chem. Soc. 114 (1992) 4021-4027
89. Suzuki T., Yamada M., Furukawa H., Kanaori K., Tajima K., and Makino K. Detection of 2′-deoxyoxanosine by capillary electrophoresis. Nucleic Acids Symp. Ser. 37 (1997) 239-240
90. Suzuki T., Yoshida M., Yamada M., Ide H., Kobayashi M., Kanaori K., Tajima K., and Makino K. Misincorporation of 2′-deoxyoxanosine 5′-triphosphate by DNA polymerases and its implication for mutagenesis. Biochemistry 37 (1998) 11592-11598
91. T. Suzuki, M. Yamada, T. Ishida, T. Morii, K. Makino, Reactivity of 2′-deoxyoxanosine, a novel DNA lesion, Nucleic Acids Symp. Ser. (1999) 7-8.
92. Suzuki T., Ide H., Yamada M., Endo N., Kanaori K., Tajima K., Morii T., and Makino K. Formation of 2′-deoxyoxanosine from 2′-deoxyguanosine and nitrous acid: mechanism and intermediates. Nucleic Acids Res. 28 (2000) 544-551
93. Suzuki T., Yamada M., Ide H., Kanaori K., Tajima K., Morii T., and Makino K. Identification and characterization of a reaction product of 2′-deoxyoxanosine with glycine. Chem. Res. Toxicol. 13 (2000) 227-230
94. Terato H., Masaoka A., Asagoshi K., Honsho A., Ohyama Y., Suzuki T., Yamada M., Makino K., Yamamoto K., and Ide H. Novel repair activities of AlkA (3-methyladenine DNA glycosylase II) and endonuclease VIII for xanthine and oxanine, guanine lesions induced by nitric oxide and nitrous acid. Nucleic Acids Res. 30 (2002) 4975-4984
95. Nakano T., Asagoshi K., Terato H., Suzuki T., and Ide H. Assessment of the genotoxic potential of nitric oxide-induced guanine lesions by in vitro reactions with Escherichia coli DNA polymerase I. Mutagenesis 20 (2005) 209-216
96. Nakano T., Katafuchi A., Shimizu R., Terato H., Suzuki T., Tauchi H., Makino K., Skorvaga M., Van Houten B., and Ide H. Repair activity of base and nucleotide excision repair enzymes for guanine lesions induced by nitrosative stress. Nucleic Acids Res. 33 (2005) 2181-2191
97. Nakano T., Terato H., Asagoshi K., Ohyama Y., Suzuki T., Yamada M., Makino K., and Ide H. Adduct formation between oxanine and amine derivatives. Nucleic Acids Res Suppl. 1 (2001) 47-48
98. Nakano T., Terato H., Asagoshi K., Masaoka A., Mukuta M., Ohyama Y., Suzuki T., Makino K., and Ide H. DNA-protein cross-link formation mediated by oxanine. A novel genotoxic mechanism of nitric oxide-induced DNA damage. J. Biol. Chem. 278 (2003) 25264-25272
99. Suzuki T., Yamada M., Ide H., Kanaori K., Tajima K., Morii T., and Makino K. Influence of ring opening-closure equilibrium of oxanine a novel damaged nucleobase, on migration behavior in capillary electrophoresis. J. Chromatogr. A 877 (2000) 225-232
100. Wang C., and Deen W.M. Nitric oxide delivery system for cell culture studies. Ann. Biomed. Eng. 31 (2003) 65-79
101. Mirvish S.S. Formation of N-nitroso compounds: chemistry kinetics, and in vivo occurrence. Toxicol. Appl. Pharmacol. 31 (1975) 325-351
102. B.C. Challis, D.E.G. Shuker, D.H. Fine, E.U. Goff, G.A. Hoffman, Amine nitration and nitrosation by gaseous nitrogen dioxide, in: H. Bartsch, I.K. O'Neill, M. Castegnaro, M. Okada (Eds.), N-nitroso Compounds: Occurrence and Biological Effects, IARC, Lyon, 1981, pp. 11-20.
103. Kirchner J.J., and Hopkins P.B. Nitrous acid cross-links duplex DNA fragments through deoxyguanosine residues at the sequence 5′-CG. J. Am. Chem. Soc. 113 (1991) 4681-4682
104. Glaser R., Wu H., and Lewis M. Cytosine catalysis of nitrosative guanine deamination and interstrand cross-link formation. J. Am. Chem. Soc. 127 (2005) 7346-7358
105. Glaser R. Pyrimidine ring opening in the unimolecular dediazoniation of guanine diazonium ion. An ab initio theoretical study of the mechanism of nitrosative guanosine deamination. J. Am. Chem. Soc. 118 (1996) 10942-10943
106. Glaser R., Sundeep R., Lewis M., Son M.-S., and Meyer S. Theoretical studies of DNA base deamination. 2. Ab initio study of DNA base diazonium ions and of their linear, unimolecular dediazoniation paths. J. Am. Chem. Soc. 121 (1999) 6108-6119
107. Glaser R., and Lewis M. Single- and double-proton-transfer in the aggregate between cytosine and guaninediazonium ion. Org. Lett. 2 (1999) 273-276
108. Qian M., and Glaser R. Demonstration of an alternative mechanism for G-to-G cross-link formation. J. Am. Chem. Soc. 127 (2005) 880-887
109. Rayat S., Wu Z., and Glaser R. Nitrosative guanine deamination: ab initio study of deglycation of N-protonated 5-cyanoimino-4-oxomethylene-4,5-dihydroimidazoles. Chem. Res. Toxicol. 17 (2004) 1157-1169
110. Rayat S., Majumdar P., Tipton P., and Glaser R. 5-Cyanoimino-4-oxomethylene-4,5-dihydroimidazole and 5-cyanoamino-4-imidazolecarboxylic acid intermediates in nitrosative guanosine deamination: evidence from 18O-labeling experiments. J. Am. Chem. Soc. 126 (2004) 9960-9969
111. Qian M., and Glaser R. 5-Cyanoamino-4-imidazolecarboxamide and nitrosative guanine deamination: experimental evidence for pyrimidine ring-opening during deamination. J. Am. Chem. Soc. 126 (2004) 2274-2275
112. Rayat S., and Glaser R. 5-Cyanoimino-4-oxomethylene-4,5-dihydroimidazole and nitrosative guanine deamination. A theoretical study of geometries, electronic structures, and N-protonation. J. Org. Chem. 68 (2003) 9882-9892
113. Hodgen B., Rayat S., and Glaser R. Nitrosative adenine deamination: facile pyrimidine ring-opening in the dediazoniation of adeninediazonium ion. Org. Lett. 5 (2003) 4077-4080
114. deRojas-Walker T., Tamir S., Ji H., Wishnok J.S., and Tannenbaum S.R. Nitric oxide induces oxidative damage in addition to deamination in macrophages. Chem. Res. Toxicol. 8 (1995) 473-477
115. Longacre A., and Storb U. A novel cytidine deaminase affects antibody diversity. Cell 102 (2000) 541-544
116. Harris R.S., Sheehy A.M., Craig H.M., Malim M.H., and Neuberger M.S. DNA deamination: not just a trigger for antibody diversification but also a mechanism for defense against retroviruses. Nat. Immunol. 4 (2003) 641-643
117. Chaudhuri J., and Alt F.W. Class-switch recombination: interplay of transcription, DNA deamination and DNA repair. Nat. Rev. Immunol. 4 (2004) 541-552
118. Pham P., Bransteitter R., and Goodman M.F. Reward versus risk: DNA cytidine deaminases triggering immunity and disease. Biochemistry 44 (2005) 2703-2715
119. Muramatsu M., Sankaranand V.S., Anant S., Sugai M., Kinoshita K., Davidson N.O., and Honjo T. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J. Biol. Chem. 274 (1999) 18470-18846
120. Muramatsu M., Kinoshita K., Fagarasan S., Yamada S., Shinkai Y., and Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102 (2000) 553-563
121. Papavasiliou F.N., and Schatz D.G. Somatic hypermutation of immunoglobulin genes: merging mechanisms for genetic diversity. Cell 109 Suppl (2002) S35-S44
122. Martin A., and Scharff M.D. AID and mismatch repair in antibody diversification. Nat. Rev. Immunol. 2 (2002) 605-614
123. Petersen-Mahrt S.K., Harris R.S., and Neuberger M.S. AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature 418 (2002) 99-103
124. Rada C., Di Noia J.M., and Neuberger M.S. Mismatch recognition and uracil excision provide complementary paths to both Ig switching and the A/T-focused phase of somatic mutation. Mol. Cell. 16 (2004) 163-171
125. Di Noia J., and Neuberger M.S. Altering the pathway of immunoglobulin hypermutation by inhibiting uracil-DNA glycosylase. Nature 419 (2002) 43-48
126. Nagaoka H., Ito S., Muramatsu M., Nakata M., and Honjo T. DNA cleavage in immunoglobulin somatic hypermutation depends on de novo protein synthesis but not on uracil DNA glycosylase. Proc. Natl. Acad. Sci. USA 102 (2005) 2022-2027
127. Neuberger M.S., Di Noia J.M., Beale R.C., Williams G.T., Yang Z., and Rada C. Somatic hypermutation at A.T pairs: polymerase error versus dUTP incorporation. Nat. Rev. Immunol. 5 (2005) 171-178
128. Anant S., and Davidson N.O. Molecular mechanisms of apolipoprotein B mRNA editing. Curr. Opin. Lipidol. 12 (2001) 159-165
129. Ito S., Nagaoka H., Shinkura R., Begum N., Muramatsu M., Nakata M., and Honjo T. Activation-induced cytidine deaminase shuttles between nucleus and cytoplasm like apolipoprotein B mRNA editing catalytic polypeptide 1. Proc. Natl. Acad. Sci. USA 101 (2004) 1975-1980
130. Ta V.T., Nagaoka H., Catalan N., Durandy A., Fischer A., Imai K., Nonoyama S., Tashiro J., Ikegawa M., Ito S., Kinoshita K., Muramatsu M., and Honjo T. AID mutant analyses indicate requirement for class-switch-specific cofactors. Nat. Immunol. 4 (2003) 843-848
131. Barreto V., Reina-San-Martin B., Ramiro A.R., McBride K.M., and Nussenzweig M.C. C-terminal deletion of AID uncouples class switch recombination from somatic hypermutation and gene conversion. Mol. Cell 12 (2003) 501-508
132. Pham P., Bransteitter R., Petruska J., and Goodman M.F. Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation. Nature 424 (2003) 103-107
133. Bransteitter R., Pham P., Calabrese P., and Goodman M.F. Biochemical analysis of hypermutational targeting by wild type and mutant activation-induced cytidine deaminase. J. Biol. Chem. 279 (2004) 51612-51621
134. Hopper A.K., and Phizicky E.M. tRNA transfers to the limelight. Genes Devel. 17 (2003) 162-180
135. Bjork G.R. Biosynthesis and function of modified nucleosides. In: Söll D., and RajBhandary U.L. (Eds). tRNA: Structure, Biosynthesis and Function (1995), ASM Press, Washingtton, DC 165-205
136. Keegan L.P., Leroy A., Sproul D., and O'Connell M.A. Adenosine deaminases acting on RNA (ADARs): RNA-editing enzymes. Genome Biol. 5 (2004) 209
137. Hoopengardner B., Bhalla T., Staber C., and Reenan R. Nervous system targets of RNA editing identified by comparative genomics. Science 301 (2003) 832-836
138. Bass B.L., and Weintraub H. An unwinding activity that covalently modifies its double-stranded RNA substrate. Cell 55 (1988) 1089-1098
139. Bass B.L., and Weintraub H. A developmentally regulated activity that unwinds RNA duplexes. Cell 48 (1987) 607-613
140. Wagner R.W., Smith J.E., Cooperman B.S., and Nishikura K. A double-stranded RNA unwinding activity introduces structural alterations by means of adenosine to inosine conversions in mammalian cells and Xenopus eggs. Proc. Natl. Acad. Sci. USA 86 (1989) 2647-2651
141. Rebagliati M.R., and Melton D.A. Antisense RNA injections in fertilized frog eggs reveal an RNA duplex unwinding activity. Cell 48 (1987) 599-605
142. Gerber A.P., and Keller W. RNA editing by base deamination: more enzymes, more targets, new mysteries. Trends Biochem. Sci. 26 (2001) 376-384
143. Gott J.M., and Emeson R.B. Functions and mechanisms of RNA editing. Annu. Rev. Genet. 34 (2000) 499-531
144. Maas S., and Rich A. Changing genetic information through RNA editing. Bioessays 22 (2000) 790-802
145. Seeburg P.H. A-to-I editing. New and old sites, functions and speculations. Neuron 35 (2002) 17-20
146. Sommer B., Kohler M., Sprengel R., and Seeburg P.H. RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. Cell 67 (1991) 11-19
147. Higuchi M., Single F.N., Kohler M., Sommer B., Sprengel R., and Seeburg P.H. RNA editing of AMPA receptor subunit GluR-B: a base-paired intron-exon structure determines position and efficiency. Cell 75 (1993) 1361-1370
148. Seeburg P.H., Higuchi M., and Sprengel R. RNA editing of brain glutamate receptor channels: mechanism and physiology. Brain Res. Rev. 26 (1998) 217-229
149. Burns C.M., Chu H., Rueter S.M., Hutchinson L.K., Canton H., Sanders-Bush E., and Emeson R.B. Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature 387 (1997) 303-308
150. Sanders-Bush E., Fentress H., and Hazelwood L. Serotonin 5-ht2 receptors: molecular and genomic diversity. Mol. Interv. 3 (2003) 319-330
151. Bhalla T., Rosenthal J.J., Holmgren M., and Reenan R. Control of human potassium channel inactivation by editing of a small mRNA hairpin. Nat. Struct. Mol. Biol. 11 (2004) 950-956
152. Levanon E.Y., Eisenberg E., Yelin R., Nemzer S., Hallegger M., Shemesh R., Fligelman Z.Y., Shoshan A., Pollock S.R., Sztybel D., Olshansky M., Rechavi G., and Jantsch M.F. Systematic identification of abundant A-to-I editing sites in the human transcriptome. Nat. Biotechnol. 22 (2004) 1001-1005
153. Levanon E.Y., Hallegger M., Kinar Y., Shemesh R., Djinovic-Carugo K., Rechavi G., Jantsch M.F., and Eisenberg E. Evolutionarily conserved human targets of adenosine to inosine RNA editing. Nucleic Acids Res. 33 (2005) 1162-1168
154. Higuchi M., Maas S., Single F.N., Hartner J., Rozov A., Burnashev N., Feldmeyer D., Sprengel R., and Seeburg P.H. Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2. Nature 406 (2000) 78-81
155. Jia Z., Agopyan N., Miu P., Xiong Z., Henderson J., Gerlai R., Taverna F.A., Velumian A., MacDonald J., Carlen P., Abramow-Newerly W., and Roder J. Enhanced LTP in mice deficient in the AMPA receptor GluR2. Neuron 17 (1996) 945-956
156. Blanc V., and Davidson N.O. C-to-U RNA editing: mechanisms leading to genetic diversity. J. Biol. Chem. 278 (2003) 1395-1398
157. Anant S., Blanc V., and Davidson N.O. Molecular regulation, evolutionary, and functional adaptations associated with C to U editing of mammalian apolipoproteinB mRNA. Prog. Nucleic Acid Res. Mol. Biol. 75 (2003) 1-41
158. Jarmuz A., Chester A., Bayliss J., Gisbourne J., Dunham I., Scott J., and Navaratnam N. An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics 79 (2002) 285-296
159. Wang Q., Zhang Z., Blackwell K., and Carmichael G.G. Vigilins bind to promiscuously A-to-I-edited RNAs and are involved in the formation of heterochromatin. Curr. Biol. 15 (2005) 384-391
160. Blount B.C., Mack M.M., Wehr C.M., MacGregor J.T., Hiatt R.A., Wang G., Wickramasinghe S.N., Everson R.B., and Ames B.N. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc. Natl. Acad. Sci. USA 94 (1997) 3290-3295
161. Han J., Hankinson S.E., Zhang S.M., De Vivo I., and Hunter D.J. Interaction between genetic variations in DNA repair genes and plasma folate on breast cancer risk. Cancer Epidemiol. Biomarkers Prev. 13 (2004) 520-524
162. Duthie S.J., Narayanan S., Sharp L., Little J., Basten G., and Powers H. Folate DNA stability and colo-rectal neoplasia. Proc. Nutr. Soc. 63 (2004) 571-578
163. Narayanan S., McConnell J., Little J., Sharp L., Piyathilake C.J., Powers H., Basten G., and Duthie S.J. Associations between two common variants C677T and A1298C in the methylenetetrahydrofolate reductase gene and measures of folate metabolism and DNA stability (strand breaks, misincorporated uracil, and DNA methylation status) in human lymphocytes in vivo. Cancer Epidemiol. Biomarkers Prev. 13 (2004) 1436-1443
164. Curto R., Voit E.O., Sorribas A., and Cascante M. Mathematical models of purine metabolism in man. Math. Biosci. 151 (1998) 1-49
165. Zubay G.L. Biochemistry. 4th edition (1998), W.C. Brown Publishers, Dubuque
166. Thelander L., and Reichard P. Reduction of ribonucleotides. Annu. Rev. Biochem. 48 (1979) 133-158
167. Nordenskjold B.A., Skoog L., Brown N.C., and Reichard P. Deoxyribonucleotide pools and deoxyribonucleic acid synthesis in cultured mouse embryo cells. J. Biol. Chem. 245 (1970) 5360-5368
168. Meuth M. The molecular basis of mutations induced by deoxyribonucleoside triphosphate pool imbalances in mammalian cells. Exp. Cell Res. 181 (1989) 305-316
169. Loeb L.A., and Kunkel T.A. Fidelity of DNA synthesis. Annu. Rev. Biochem. 51 (1982) 429-457
170. Thompson L.F., Vaughn J.G., Laurent A.B., Blackburn M.R., and Van De Wiele C.J. Mechanisms of apoptosis in developing thymocytes as revealed by adenosine deaminase-deficient fetal thymic organ cultures. Biochem. Pharmacol. 66 (2003) 1595-1599
171. Ullman B., Gudas L.J., Cohen A., and Martin Jr. D.W. Deoxyadenosine metabolism and cytotoxicity in cultured mouse T lymphoma cells: a model for immunodeficiency disease. Cell 14 (1978) 365-375
172. Weinberg G., Ullman B., and Martin Jr. D.W. Mutator phenotypes in mammalian cell mutants with distinct biochemical defects and abnormal deoxyribonucleoside triphosphate pools. Proc. Natl. Acad. Sci. USA 78 (1981) 2447-2451
173. Sargent R.G., and Mathews C.K. Imbalanced deoxyribonucleoside triphosphate pools and spontaneous mutation rates determined during dCMP deaminase-defective bacteriophage T4 infections. J. Biol. Chem. 262 (1987) 5546-5553
174. Lu Q., Zhang X., Almaula N., Mathews C.K., and Inouye M. The gene for nucleoside diphosphate kinase functions as a mutator gene in Escherichia coli. J. Mol. Biol. 254 (1995) 337-341
175. Stanbury J.B. The Metabolic Basis of Inherited Disease. 5th edition (1983), McGraw-Hill, New York
176. Jaeken J., and Van den Berghe G. An infantile autistic syndrome characterised by the presence of succinylpurines in body fluids. Lancet 2 (1984) 1058-1061
177. Van den Berghe G., Vincent M.F., and Jaeken J. Inborn errors of the purine nucleotide cycle: adenylosuccinase deficiency. J. Inherit. Metab. Dis. 20 (1997) 193-202
178. Marie S., Race V., Nassogne M.C., Vincent M.F., and Van den Berghe G. Mutation of a nuclear respiratory factor 2 binding site in the 5′ untranslated region of the ADSL gene in three patients with adenylosuccinate lyase deficiency. Am. J. Hum. Genet. 71 (2002) 14-21
179. Vanderheiden B.S. Genetic studies of human erythrocyte inosine triphosphatase. Biochem. Genet. 3 (1969) 289-297
180. Valerio D., Duyvesteyn M.G., van Ormondt H., Meera Khan P., and van der
181. Chung J.H., Back J.H., Park Y.I., and Han Y.S. Biochemical characterization of a novel hypoxanthine/xanthine dNTP pyrophosphatase from Methanococcus jannaschii. Nucleic Acids Res. 29 (2001) 3099-3107
182. Chung J.H., Park H.Y., Lee J.H., and Jang Y. Identification of the dITP- and XTP-hydrolyzing protein from Escherichia coli. J. Biochem. Mol. Biol. 35 (2002) 403-408
183. Lin S., McLennan A.G., Ying K., Wang Z., Gu S., Jin H., Wu C., Liu W., Yuan Y., Tang R., Xie Y., and Mao Y. Cloning, expression, and characterization of a human inosine triphosphate pyrophosphatase encoded by the itpa gene. J. Biol. Chem. 276 (2001) 18695-18701
184. Clyman J., and Cunningham R.P. Escherichia coli K-12 mutants in which viability is dependent on recA function. J. Bacteriol. 169 (1987) 4203-4210
185. Clyman J., and Cunningham R.P. Suppression of the defects in rdgB mutants of Escherichia coli K-12 by the cloned purA gene. J. Bacteriol. 173 (1991) 1360-1362
186. Noskov V.N., Staak K., Shcherbakova P.V., Kozmin S.G., Negishi K., Ono B.C., Hayatsu H., and Pavlov Y.I. HAM1, the gene controlling 6-N-hydroxylaminopurine sensitivity and mutagenesis in the yeast Saccharomyces cerevisiae. Yeast 12 (1996) 17-29
187. Burgis N.E., Brucker J.J., and Cunningham R.P. Repair system for noncanonical purines in Escherichia coli. J. Bacteriol. 185 (2003) 3101-3110
188. Bradshaw J.S., and Kuzminov A. RdgB acts to avoid chromosome fragmentation in Escherichia coli. Mol. Microbiol. 48 (2003) 1711-1725
189. Demple B., and Linn S. On the recognition and cleavage mechanism of Escherichia coli endodeoxyribonuclease V, a possible DNA repair enzyme. J. Biol. Chem. 257 (1982) 2848-2855
190. Yao M., Hatahet Z., Melamede R.J., and Kow Y.W. Purification and characterization of a novel deoxyinosine-specific endonuclease enzyme, deoxyinosine 3′-endonuclease, from Eschericia coli. J. Biol. Chem. 269 (1994) 16260-16268
191. Kow Y.W. Repair of deaminated bases in DNA. Free Radic. Biol. Med. 33 (2002) 886-893
192. He B., Qing H., and Kow Y.W. Deoxyxanthosine in DNA is repaired by Escherichia coli endonuclease V. Mutat. Res. 459 (2000) 109-114
193. Huang J., Lu J., Barany F., and Cao W. Multiple cleavage activities of endonuclease V from Thermotoga maritima: recognition and strand nicking mechanism. Biochemistry 40 (2001) 8738-8748
194. Hitchcock T.M., Gao H., and Cao W. Cleavage of deoxyoxanosine-containing oligodeoxyribonucleotides by bacterial endonuclease V. Nucleic Acids Res. 32 (2004) 4071-4080
195. Saparbaev M., and Laval J. Excision of hypoxanthine from DNA containing dIMP residues by the Escherichia coli, yeast, rat, and human alkylpurine DNA glycosylase. Proc. Natl. Acad. Sci. USA 91 (1994) 5873-5877
196. Mansfield C., Kerins S.M., and McCarthy T.V. Characterisation of Archaeglobus fulgidus AlkA hypoxanthine DNA glycosylase activity. FEBS Lett. 540 (2003) 171-175
197. Guo G., and Weiss B. Endonuclease V (nfi) mutant of Escherichia coli K-12. J. Bacteriol. 180 (1998) 46-51
198. B.K. Duncan, B. Weiss, in: P.C. Hanawalt, E.C. Friedberg, F.C. F. (Eds.), DNA Repair Mechanisms, Academic Press, New York, 1978, pp. 183-186.
199. Coulondre C., Miller J.H., Farabaugh P.J., and Gilbert W. Molecular basis of base substitution hotspots in Escherichia coli. Nature 274 (1978) 775-780
200. Duncan B.K., and Miller J.H. Mutagenic deamination of cytosine residues in DNA. Nature 287 (1980) 560-561
201. Eritja R., Horowitz D.M., Walker P.A., Ziehler-Martin J.P., Boosalis M.S., Goodman M.F., Itakura K., and Kaplan B.E. Synthesis and properties of oligonucleotides containing 2′-deoxynebularine and 2′-deoxyxanthosine. Nucleic Acids Res. 14 (1986) 8135-8153
202. Kamiya H., Miura H., Suzuki M., Murata N., Ishikawa H., Shimizu M., Komatsu Y., Murata T., Sasaki T., and Inoue H. Mutations induced by DNA lesions in hot spots of the c-Ha-ras gene. Nucleic Acids Symp. Ser. 27 (1992) 179-180
203. Loeb L.A., and Preston B.D. Mutagenesis by apurinic/apyrimidinic sites. Annu. Rev. Genet. 20 (1986) 201-230
204. Boiteux S., and Laval J. Coding properties of poly(deoxycytidylic acid) templates containing uracil or apyrimidinic sites: in vitro modulation of mutagenesis by deoxyribonucleic acid repair enzymes. Biochemistry 21 (1982) 6746-6751
205. Strauss B., Rabkin S., Sagher D., and Moore P. The role of DNA polymerase in base substitution mutagenesis on non-instructional templates. Biochimie 64 (1982) 829-838
206. Wong T.S., Tee K.L., Hauer B., and Schwaneberg U. Sequence saturation mutagenesis (SeSaM): a novel method for directed evolution. Nucleic Acids Res. 32 (2004) e26
207. Spee J.H., de Vos W.M., and Kuipers O.P. Efficient random mutagenesis method with adjustable mutation frequency by use of PCR and dITP. Nucleic Acids Res. 21 (1993) 777-778
208. Kawase Y., Iwai S., Inoue H., Miura K., and Ohtsuka E. Studies on nucleic acid interactions. I. Stabilities of mini-duplexes (dG2A4XA4G2-dC2T4YT4C2) and self-complementary d(GGGAAXYTTCCC) containing deoxyinosine and other mismatched bases. Nucleic Acids Res. 14 (1986) 7727-7736
209. Hill-Perkins M., Jones M.D., and Karran P. Site-specific mutagenesis in vivo by single methylated or deaminated purine bases. Mutat. Res. 162 (1986) 153-163
210. Turney T.A., and Wright G.A. Nitrous acid and nitrosation. Chem. Rev. 59 (1959) 497-513
211. Sidorkina O., Saparbaev M., and Laval J. Effects of nitrous acid treatment on the survival and mutagenesis of Escherichia coli cells lacking base excision repair (hypoxanthine-DNA glycosylase-ALK A protein) and/or nucleotide excision repair. Mutagenesis 12 (1997) 23-28
212. Schouten K.A., and Weiss B. Endonuclease V protects Escherichia coli against specific mutations caused by nitrous acid. Mutat. Res. 435 (1999) 245-254
213. Spek E.J., Wright T.L., Stitt M.S., Taghizadeh N.R., Tannenbaum S.R., Marinus M.G., and Engelward B.P. Recombinational repair is critical for survival of Escherichia coli exposed to nitric oxide. J. Bacteriol. 183 (2001) 131-138
214. Spek E.J., Vuong L.N., Matsuguchi T., Marinus M.G., and Engelward B.P. Nitric oxide-induced homologous recombination in Escherichia coli is promoted by DNA glycosylases. J. Bacteriol. 184 (2002) 3501-3507
215. Hori M., Ishiguro C., Harashima H., and Kamiya H. In vivo mutagenicities of damaged nucleotides produced by nitric oxide and ionizing radiation. Biol. Pharm. Bull. 28 (2005) 520-522